BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11094569)

  • 1. [Is bone marrow inhibition a special risk in connection with olanzapine (Zyprexa) treatment?].
    Gram LF
    Ugeskr Laeger; 2000 Oct; 162(44):5961. PubMed ID: 11094569
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine (Zyprexa): suspected serious reactions.
    Cadario B
    CMAJ; 2000 Jul; 163(1):85-6, 89-90. PubMed ID: 10920744
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine and serotonin toxicity.
    Isbister GK; Downes F; Whyte IM
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):241-2. PubMed ID: 12667176
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
    Gram LF
    Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine-induced retarded ejaculation: role of paroxetine comedication? A case report.
    Bizouard P; Vandel S; Kantelip JP
    Therapie; 2001; 56(4):443-5. PubMed ID: 11677871
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome associated with olanzapine].
    García López MM; Ciprés L; de Cendra E; Vilalta Franch J
    Med Clin (Barc); 1999 Sep; 113(6):239. PubMed ID: 10472615
    [No Abstract]   [Full Text] [Related]  

  • 7. Eosinophilia associated with olanzapine.
    Mathias S; Schaaf LW; Sonntag A
    J Clin Psychiatry; 2002 Mar; 63(3):246-7. PubMed ID: 11928731
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible leucopenia related to olanzapine.
    Meissner W; Schmidt T; Kupsch A; Trottenberg T; Lempert T
    Mov Disord; 1999 Sep; 14(5):872-3. PubMed ID: 10495055
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine. Keep an eye on this neuroleptic.
    Can Fam Physician; 2000 Feb; 46():322-6, 330-6. PubMed ID: 10690489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuing treatment with novel antipsychotic drugs despite leukopenia or thrombocytopenia.
    Jackson RS
    Arch Gen Psychiatry; 2001 Jul; 58(7):706-7. PubMed ID: 11448379
    [No Abstract]   [Full Text] [Related]  

  • 11. [The change from clozapine to olanzapine--same effect?].
    Pomp E
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):945-6. PubMed ID: 10795501
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperglycemia and ketoacidosis associated with olanzapine].
    Von Hayek D; Hüttl V; Reiss J; Schweiger HD; Füessl HS
    Nervenarzt; 1999 Sep; 70(9):836-7. PubMed ID: 10522253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone.
    Dernovsek MZ; Tavcar R
    Int Clin Psychopharmacol; 2000 Jul; 15(4):237-8. PubMed ID: 10954065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
    Weimer E; Braus DF; Cavus I; Thome J
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution.
    Teter CJ; Early JJ; Frachtling RJ
    J Clin Psychiatry; 2000 Nov; 61(11):872-3. PubMed ID: 11105743
    [No Abstract]   [Full Text] [Related]  

  • 16. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
    Melkersson K; Hulting AL
    Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762
    [No Abstract]   [Full Text] [Related]  

  • 17. Can olanzapine be implicated in causing serotonin syndrome?
    Haslett CD; Kumar S
    Psychiatry Clin Neurosci; 2002 Oct; 56(5):533-5. PubMed ID: 12193243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.
    Francobandiera G
    Can J Psychiatry; 2001 May; 46(4):356-8. PubMed ID: 11387793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
    Hong X; Wang X
    Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid resolution of antipsychotic-induced tardive dyskinesia with olanzapine.
    Khan M; Farver D
    S D J Med; 2000 Feb; 53(2):65-7. PubMed ID: 10731859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.